Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

PTIXW
Protagenic Therapeutics, Inc. Warrant
stock NASDAQ Warrant

At Close
May 9, 2025
0.0073USD0.000%(0.0000)1,088
0.00Bid   0.00Ask   0.0000Spread
Pre-market
Dec 31, 1969 7:00:00 PM EST
0.00USD-100.000%(-0.01)0
After-hours
May 9, 2025 4:00:30 PM EDT
0.0074USD0.000%(+0.0074)500
OverviewHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Nov 16, 2021
09:58AM EST  Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today announced results for the third quarter ended September 30, 2021.   GlobeNewswire Inc
Aug 30, 2021
09:15AM EDT  Scientific rationale and evidence for PT00114 in the treatment of Depression, Anxiety, PTSD and Addiction to be discussed   GlobeNewswire Inc
Aug 17, 2021
07:45AM EDT  Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today announced results for the second quarter ended June 30, 2021.   GlobeNewswire Inc
Jul 23, 2021
04:21PM EDT  Protagenic Therapeutics Updates Timeline for Commencement of   GlobeNewswire Inc
Jul 6, 2021
06:17AM EDT  Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today announced that it will host a key opinion leader (KOL) webinar focused on PT00114 for the regulation of stress in patients with Depression, PTSD, Anxiety and Addiction on Tuesday, July 13 at 10:00AM ET.   GlobeNewswire Inc
Jun 16, 2021
09:15AM EDT  Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a bioharmaceutical company focused on developing drug product candidates to treat stress-related neurologic disorders, today announced will be presenting at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference tomorrow, June 17, 2021. The presentation details are as follows:   GlobeNewswire Inc
Apr 29, 2021
03:06PM EDT  Protagenic Therapeutics, Inc. Announces Closing of $13.2 Million   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC